Pharmcol testing

Ended Purchase Order Awarded Last action

Contract number
15DDHQ26P00000801
Awardee
Awarding agency
Obligated
$42,870

Award facts

Contract value 100% obligated
$42,870.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 2 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Ann Arbor, MI 48108, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 · Title: purchase of drugs for pharmcol testing $0
Original award $42,870

About this award

The Drug Enforcement Administration awarded a purchase order to Cayman Chemical Co Inc. for $42,870 on July 28, 2026, for the purchase of drugs for pharmacological testing, with delivery due August 31, 2026 and final completion September 30, 2026.

Place of performance is Ann Arbor, Michigan. The order is priced firm fixed price with no small business set-aside. Cayman Chemical manufactures controlled substances, opioids, and novel psychoactive compounds in small quantities for DEA pharmacological testing, diversion control, and abuse potential evaluation.

Quick answers

Who was awarded contract 15DDHQ26P00000801?

15DDHQ26P00000801 was awarded to Cayman Chemical Co Inc. by Drug Enforcement Administration (Department of Justice) on July 28, 2026.

How much is contract 15DDHQ26P00000801 worth?

The government has obligated $42,870 on 15DDHQ26P00000801.

Was contract 15DDHQ26P00000801 competed?

The extent of competition for 15DDHQ26P00000801 was competed under sap. The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award